Abstract 4371163: Stroke subtypes Loeys-Dietz and Vascular Ehlers-Danlos Syndromes: A Multicenter Retrospective Cohort Study

L Luke Dreher (Mayo Clinic Arizona, Phoenix, Arizona, United States) H Hussein Abdul Nabi (Mayo Clinic Arizona, Phoenix, Arizona, United States) H Hend Bcharah (Mayo Clinic Arizona, Phoenix, Arizona, United States) G George Bcharah (Mayo Clinic Arizona, Phoenix, Arizona, United States) L Linnea Baudhuin (MAYO CLINIC, Rochester, Minnesota, United States) M Mayowa Osundiji (Mayo Clinic Arizona, Phoenix, Arizona, United States) H Hicham El Masry (Mayo CLinic AZ, Phoenix, Arizona, United States) F Fadi Shamoun (Mayo Clinic Arizona, Phoenix, Arizona, United States)

Abstract

Background: Loeys-Dietz syndrome (LDS) and vascular Ehlers-Danlos syndrome (vEDS) are rare connective tissue disorders characterized by arterial fragility and early-onset vascular events. Stroke risk is elevated in both conditions, but data on stroke subtypes and anticoagulation use remain limited. Understanding the relationship between stroke mechanisms, arrhythmias, and antithrombotic therapy is crucial in these genetically vulnerable populations. Aim: To assess the prevalence and subtypes of stroke in patients with LDS and vEDS. Methods: A retrospective chart review was conducted across three Mayo Clinic sites. Patients with LDS and vEDS were identified using an electronic data extraction tool, followed by manual chart review for diagnostic confirmation. Stroke subtypes, ischemic, dissection-related, and hemorrhagic, were classified based on imaging findings and clinical documentation. Data on atrial arrhythmias, valve replacement status, and anticoagulation use (including warfarin and apixaban) were systematically collected and analyzed. Results: In the LDS cohort, 12 of 94 patients (12.8%) experienced a stroke: 8 ischemic (8.5%), 3 dissection-related (3.2%), and 1 hemorrhagic (1.1%). Atrial fibrillation or flutter was present in 7 patients (58.3%), 6 of whom had ischemic strokes. Among the stroke patients, 9 (75%) had prosthetic valves, 6 mechanical and 3 bioprosthetic, and 4 (33.3%) were on warfarin at the time of the event. In the vEDS cohort, 22 of 132 patients (16.7%) had strokes: 13 ischemic (9.8%) and 9 dissection-related (6.8%). No hemorrhagic strokes were observed. Atrial fibrillation or flutter was documented in 12 patients (54.5%), with 10 experiencing ischemic and 2 dissection-related strokes. Of these, 5 (22.7%) were on apixaban, 3 (13.6%) on warfarin, and 4 (18.2%) were not anticoagulated. None of the vEDS stroke patients had mechanical valves. Conclusion: Ischemic stroke is the most frequent cerebrovascular event in both LDS and vEDS, but dissection-related strokes are more common in vEDS. Atrial arrhythmias often precede ischemic events, yet anticoagulation use varies widely. One-third of dissection-related strokes occurred despite antithrombotic therapy, raising concerns about current management strategies. These findings support the need for syndrome-specific guidelines for stroke prevention, arrhythmia management, and anticoagulation in LDS and vEDS patients.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (8)

L

Luke Dreher

Mayo Clinic Arizona, Phoenix, Arizona, United States

H

Hussein Abdul Nabi

Mayo Clinic Arizona, Phoenix, Arizona, United States

H

Hend Bcharah

Mayo Clinic Arizona, Phoenix, Arizona, United States

G

George Bcharah

Mayo Clinic Arizona, Phoenix, Arizona, United States

L

Linnea Baudhuin

MAYO CLINIC, Rochester, Minnesota, United States

M

Mayowa Osundiji

Mayo Clinic Arizona, Phoenix, Arizona, United States

H

Hicham El Masry

Mayo CLinic AZ, Phoenix, Arizona, United States

F

Fadi Shamoun

Mayo Clinic Arizona, Phoenix, Arizona, United States